US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

77.68

+0.69000.90%

Post-market: 77.680.00000.00%16:05 EDT

Volume:103.79K

Turnover:8.06M

Market Cap:3.96B

PE:25.40

High:78.20

Open:77.50

Low:76.96

Close:76.99

Loading ...

Overview Company News Filings

Cohen & Steers (NYSE:CNS) Is Paying Out A Larger Dividend Than Last Year

Simply Wall St.

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

Orion Energy Systems And 2 Other US Penny Stocks To Consider For Your Portfolio

Simply Wall St.

Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Cohen & Steers Lifts Dividend 5.1% to $0.62 per Share, Payable March 13 to Holders as of March 3

MT Newswires Live

Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)

Health Check: It’s show-and-tell time for three of our home-grown heroes

CNS Pharmaceuticals to Implement 1-for-50 Reverse Stock Split; Shares Down

MT Newswires Live

CNS Pharmaceuticals announces 1-for-50 reverse stock split

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression

Europe Approves Merck's Cancer Drug For Two Indications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNS/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"Cohen & Steers","latestPrice":77.68,"timestamp":1746648000000,"preClose":76.99,"halted":0,"volume":103787,"hourTrading":{"tag":"盘后","latestPrice":77.68,"preClose":77.68,"latestTime":"16:05 EDT","volume":5709,"amount":443475.12000000005,"timestamp":1746648314293},"delay":0,"floatShares":27543702,"shares":50979157,"eps":3.05822,"marketStatus":"Post-Mkt","change":0.69,"latestTime":"05-07 19:15:02 EDT","open":77.5,"high":78.195,"low":76.96,"amount":8056816.57615,"amplitude":0.016041,"askPrice":106.82,"askSize":4,"bidPrice":54.39,"bidSize":40,"shortable":3,"etf":0,"ttmEps":3.05822,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":76.99,"dividendRate":0.030767,"preHourTrading":{"tag":"盘前","latestPrice":78.9,"preClose":76.99,"latestTime":"09:27 EDT","volume":218,"amount":16995.221139999998,"timestamp":1746624449383},"postHourTrading":{"tag":"盘后","latestPrice":77.68,"preClose":77.68,"latestTime":"16:05 EDT","volume":5709,"amount":443475.12000000005,"timestamp":1746648314293},"volumeRatio":0.684118,"impliedVol":0.1353,"impliedVolPercentile":0.072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","floatShares":27543702,"roa":"14.72%","roe":"30.76%","lyrEps":3.000753,"volumeRatio":0.684118,"shares":50979157,"dividePrice":2.39,"high":78.195,"amplitude":0.016041,"preClose":76.99,"low":76.96,"week52Low":67.09,"pbRate":"7.80","psRate":"7.48","week52High":110.67,"institutionHeld":0.6018,"latestPrice":77.68,"committee":0.818182,"eps":3.05822,"divideRate":0.030767,"volume":103787,"delay":0,"ttmEps":3.05822,"open":77.5,"prevYearClose":92.34,"prevWeekClose":78.46,"prevMonthClose":76.32,"prevQuarterClose":80.25,"fiveDayClose":76.32,"twentyDayClose":70.24,"sixtyDayClose":86.83},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNS\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514838441","title":"Cohen & Steers (NYSE:CNS) Is Paying Out A Larger Dividend Than Last Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514838441?lang=en_us&edition=fundamental","pubTime":"2025-02-26 18:38","pubTimestamp":1740566322,"startTime":"0","endTime":"0","summary":"Cohen & Steers, Inc.  will increase its dividend from last year's comparable payment on the 13th of March to $0.62. This will take the dividend yield to an attractive 2.8%, providing a nice boost to shareholder returns.Cohen & Steers' Future Dividend Projections Appear Well Covered By Earnings. Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. Prior to this announcement, Cohen & Steers' dividend was making up a very large proportion of earnings and perhaps more concerning was that it was 149% of cash flows. This is certainly a risk factor, as reduced cash flows could force the company to pay a lower dividend.Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. Meanwhile, despite the importance of dividend payments, they are not the only factors our readers should know when assessing a company. Just as an example, we've come across 3 warning si","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-nyse-cns-paying-103842714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","CNS","NYSE"],"gpt_icon":0},{"id":"2514338099","title":"Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338099","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514338099?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 25, 2025  -- Tiziana Life Sciences, Ltd.  , a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that a nasal anti-CD3  preclinical study is nearing completion, and that foralumab could offer a novel and effective treatment for long COVID. This innovative approach works by reducing microglial activation, a key factor in the persistent brain inflammation associated with long COVID, thereby addressing the debilitating neurological and psychiatric symptoms many patients face.Previously, Tiziana conducted a human clinical study in patients with mild to moderate COVID-19 where foralumab was nasally administered once a day for 10 consecutive days. Treatment was well-tolerated and produced significant reduction in lung inflammation as assessed by computerized tomography  scanning. The aim of the human study was to assess safety of intrana","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tiziana-life-sciences-announces-long-130000505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","IE00BZ1G4Q59.USD","LU0225283273.USD","LU2133065610.SGD","LU2347655156.SGD","LU2247934214.USD","LU1162221912.USD","LU2357305700.SGD","LU2023251221.USD","BK4581","TLSA","CNS","LU1585245621.USD","BK4532","BK4127","LU0823417653.USD","LU2089284900.SGD","LU2506951875.HKD","BK4085","LU2111349929.HKD","LU1989772923.USD","BK4585","LU0950375773.USD","LU0267386448.USD","LU2506952170.USD","BK4534","LU1668664300.SGD","LU1720051017.SGD","LU2506952097.USD","EA","LU0823417737.USD","LU0158827781.USD","LU1989772840.SGD","LU0106261372.USD","LU1363072403.SGD","LU1720051108.HKD","LU0106831901.USD","BK4504","LU1430594728.SGD","LU2506951958.HKD","LU0795875169.SGD","LU2089283258.USD","LU0098860793.USD","LU0158827948.USD","LU0795875086.SGD","LU0006306889.USD","LU1732800096.USD","LU0320765646.SGD","LU0314104364.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2514509525","title":"Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2514509525","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514509525?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:00","pubTimestamp":1740484800,"startTime":"0","endTime":"0","summary":"– Showcases multiple potentially transformative near- and mid-stage therapies in ATTR amyloidosis, Cardiovascular Disease, and Neuroscience, each representing a blockbuster opportunity –。– Announces TRITON Phase 3 program for next-generation TTR silencer nucresiran in ATTR-CM and hATTR-PN, targeting durable franchise leadership –。– Highlights new clinical programs, including for Huntington’s disease, bleeding disorders, and type 2 diabetes –。Alnylam scientists will provide an update on the TRITON Phase 3 program for its next-generation transthyretin  silencer, nucresiran, which has the potential for greater than 95% knockdown with twice-annual dosing. TRITON-PN will be conducted in patients with hATTR amyloidosis with polyneuropathy, with a goal of bringing nucresiran to the market as rapidly as possible. TRITON-CM will be an event-driven cardiovascular outcomes trial in patients with ATTR amyloidosis with cardiomyopathy that, if successful, is anticipate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alnylam-highlights-significant-pipeline-progress-120000653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","LU2065732104.USD","ALNY","PRGS","BK4588","BK4135","BK4548","BK4139","CNS","BK4585"],"gpt_icon":0},{"id":"2514704449","title":"Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2514704449","media":"GuruFocus.com","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514704449?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:50","pubTimestamp":1740433810,"startTime":"0","endTime":"0","summary":"Nature, online article titled: US drug agency approves potent painkiller the first non-opioid in decades. The FDA's nod for suzetrigine bolsters confidence in the pharmaceutical industry's strategy to target sodium channels.Vertex Pharmaceuticals Inc.  has recently achieved a significant milestone with the FDA's approval of JOURNAVX, a novel non-opioid pain medication. This approval marks the introduction of the first new class of pain treatment in over two decades.GuruFocus has detected 6 Warning Signs with VRTX.Specifically the new drug will target moderate to Severe Pain, in the Acute phase as an alternative to opioid medication.The FDA approval announcement came in on January 30, 2025 as part of particular status granted to the molecule . This is a clear signal of how much the agency is looking for opioid alternatives. Tailwind for the US community and the biotech firm.In this article you can find a quick yet informative medical review of the evidence for the medication and a finan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertexs-fda-win-billion-dollar-215010625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4567","CNS","LU2462157665.USD","VERX","LU0109394709.USD","IE00BFTCPJ56.SGD","VTNR","LU0823416689.USD","LU1559883803.SGD","WAC","IE0002270589.USD","LU2236285917.USD","LU0757428866.USD","IE0009355771.USD","BK4585","LU0566484027.USD","LU2417539215.USD","LU0058720904.USD","IE00B19Z3B42.SGD","LU0061475181.USD","LU1093756325.SGD","BK4135","LU2456880835.USD","BK4588","IE00BJT1NW94.SGD","LU0234570918.USD","LU0320765992.SGD","LU1585245621.USD","LU2237438978.USD","VRTX","BK4138","LU1069344957.HKD","IE00B19Z9Z06.USD","IE0002141913.USD","LU1093756168.USD","BK4139","LU0417517546.SGD","LU0256863811.USD","BK4532","LU1035775433.USD","LU2362540622.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU1815336091.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4023","BK4533","IE00B894F039.SGD","LU0079474960.USD"],"gpt_icon":0},{"id":"2514703427","title":"Orion Energy Systems And 2 Other US Penny Stocks To Consider For Your Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703427","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514703427?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:12","pubTimestamp":1740427951,"startTime":"0","endTime":"0","summary":"As the U.S. stock market attempts to rebound from a recent sell-off, investors are exploring diverse opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, remain an intriguing option for those seeking growth at lower price points. Despite being considered somewhat outdated, these stocks can still offer significant potential when backed by strong financials and solid fundamentals.Overview: Orion Energy Systems, Inc. is involved in the research, design, development, manufacturing, marketing, sale, installation, and implementation of energy management systems for various sectors across North America and Germany with a market cap of $29.69 million.Dive into the specifics of Orion Energy Systems here with our thorough balance sheet health report.Review our growth performance report to gain insights into Orion Energy Systems' future.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-energy-systems-2-other-201231554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4021","CNS","BK4135","BK4213","BABB","BK4563","IDN","PVL","BK4157","OESX","BK4209","SB","PHX","BK4023"],"gpt_icon":0},{"id":"2513266587","title":"Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2513266587","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513266587?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"DUBLIN, Feb.  24, 2025  (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that Kevin Springman ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031098/0/en/Avadel-Pharmaceuticals-Appoints-Kevin-Springman-as-Vice-President-of-Sales.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","BK4135","BK4510","BK4085","BK4563","CNS"],"gpt_icon":0},{"id":"2513769723","title":"Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2513769723","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513769723?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400200,"startTime":"0","endTime":"0","summary":"Russell Bradley Named President & General Manager of CNSide Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley Join CNSide Board of Directors Dr. Jonathan Stein Appointed CNSide Medical Director  AUS","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031047/0/en/Plus-Therapeutics-Announces-Leadership-Appointments-for-its-CNSide-Diagnostics-Subsidiary.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSF","BK4135","NGS","BK4179","LENZ","BK4139","CNS"],"gpt_icon":0},{"id":"2513237657","title":"Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2513237657","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513237657?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:30","pubTimestamp":1740400200,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  24, 2025  (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031044/29248/en/Anavex-Life-Sciences-to-Present-at-the-45th-Annual-TD-Cowen-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","AVXL","CNS","BK4585","COWN","ET","BK4588","BK4144","BK4581","BK4590","BK4135","BK4561","BK4566","TD","BK4127","BK4139"],"gpt_icon":0},{"id":"2513401157","title":"Rapport Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2513401157","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513401157?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"BOSTON and SAN DIEGO, Feb. 24, 2025  -- Rapport Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients suffering from central nervous system  disorders, today announced that management will present at two upcoming investor conferences in March 2025.TD Cowen 45th Annual Health Care Conference  – fireside chat on Tuesday, March 4, 2025, at 3:10-3:40pm EST.Stifel 2025 Virtual CNS Forum – fireside chat on Wednesday, March 19, 2025, at 10:30-10:55am EST.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rapport-therapeutics-participate-upcoming-investor-120000075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4135","RAPP","BK4007","BK4139","CNS"],"gpt_icon":0},{"id":"2513372803","title":"Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372803","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513372803?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"SYMBRAVO demonstrated statistically significantly greater migraine treatment response compared to prior treatment with an oral CGRP inhibitor . 2-hour pain freedom for most attacks reported at least half the time by 47.9% of patients after SYMBRAVO versus 1.0% after oral CGRPs . 24-hour or greater sustained pain relief after a single dose reported by 47.9% of patients after SYMBRAVO versus 16.7% after oral CGRPs . Ability to quickly return to normal activities reported by 51.0% of patients after SYMBRAVO versus 11.5% after oral CGRPs . SYMBRAVO improved quality of life compared to after oral CGRPs . EMERGE met the primary endpoint by demonstrating statistically significantly greater migraine treatment response with SYMBRAVO compared to treatment response with prior oral CGRP inhibitors, as assessed by the mTOQ-4 total score . Statistically significantly greater proportions of patients achieved clinical response on the 2-hour pain freedom, sustained pain freedom, ability to return to no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-announces-symbravo-meloxicam-120000644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","HCP","AXSM","BK4588","BK4007","BK4505","CNS","IHS","BK4115","BK4585","BK4135"],"gpt_icon":0},{"id":"2513470207","title":"Bright Minds Biosciences to Participate at Three Healthcare Conferences in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2513470207","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513470207?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:50","pubTimestamp":1740397800,"startTime":"0","endTime":"0","summary":"NEW YORK and VANCOUVER, British Columbia, Feb.  24, 2025  (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3030985/0/en/Bright-Minds-Biosciences-to-Participate-at-Three-Healthcare-Conferences-in-March.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","CNS","BK4139","DRUG","BK4137","BK4135"],"gpt_icon":0},{"id":"2513126032","title":"Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2513126032","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513126032?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:00","pubTimestamp":1740142800,"startTime":"0","endTime":"0","summary":"Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in 2023 Full year 2024 CAPLYTA net product sales were $680.5 million, representin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/21/3030430/30597/en/Intra-Cellular-Therapies-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0106261612.USD","LU1169590202.USD","BK4135","BK4007","LU0109394709.USD","LU0053671581.USD","PD","BK4023","LU0889565916.HKD","NMS","ITCI","LU1169589451.USD","LU0012050646.USD","CNS"],"gpt_icon":0},{"id":"2513256635","title":"Cohen & Steers Lifts Dividend 5.1% to $0.62 per Share, Payable March 13 to Holders as of March 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2513256635","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513256635?lang=en_us&edition=fundamental","pubTime":"2025-02-21 16:26","pubTimestamp":1740126362,"startTime":"0","endTime":"0","summary":"Cohen & Steers Lifts Dividend 5.1% to $0.62 per Share, Payable March 13 to Holders as of March 3","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"2512441455","title":"Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512441455","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512441455?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:30","pubTimestamp":1740054600,"startTime":"0","endTime":"0","summary":"- Chemical process enhances room temperature stability -. PURCHASE, N.Y., Feb. 20, 2025  -- Cognition Therapeutics, Inc.,  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today announced that the American Chemical Society journal Organic Process Research & Development has published a manuscript describing the novel chemical process used to manufacture zervimesine . With this new manufacturing process, Cognition will be able to produce materials for future clinical studies of zervimesine. In addition, if zervimesine is approved, this process is expected to support commercial manufacturing needs.Provisional patent applications covering this chemical process and a preferred polymorphic form of zervimesine have been filed.About Cognition Therapeutics, Inc.Cognition Therapeutics, Inc., is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the CNS. We","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-announces-publication-commercial-123000600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4007","CGTX","LU0205194284.USD","DLB","LU0345774631.USD","LU0240877869.USD","LENZ","LU0345774391.USD","BK4135","LU0205193047.USD","LU0240878834.USD","BK4139","CNS","LU0348723411.USD"],"gpt_icon":0},{"id":"2512466216","title":"Health Check: It’s show-and-tell time for three of our home-grown heroes","url":"https://stock-news.laohu8.com/highlight/detail?id=2512466216","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512466216?lang=en_us&edition=fundamental","pubTime":"2025-02-20 10:54","pubTimestamp":1740020050,"startTime":"0","endTime":"0","summary":"Nanosonics says it’s on track to release its much-awaited next-generation anti-infection device this year. Cogstate’s earnings driven by Alzheimer’s disease trials growth. Sonic hoists profit by 17% but there’s no share price boom","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-945176390-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-945176390-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-its-show-and-tell-time-for-three-of-our-home-grown-healthcare-heroes/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"2512107486","title":"CNS Pharmaceuticals to Implement 1-for-50 Reverse Stock Split; Shares Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2512107486","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512107486?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:27","pubTimestamp":1739978832,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals  said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement.The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday.Shares of CNS Pharmaceuticals fell over 33% in recent trading.Price: 0.10, Change: -0.05, Percent Change: -33.33","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNS","BK4135","NQmain","CNSP","BK4007"],"gpt_icon":1},{"id":"2512102442","title":"CNS Pharmaceuticals announces 1-for-50 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2512102442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512102442?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:40","pubTimestamp":1739972408,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals (CNSP) announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company’s common stock will ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-announces-1-for-50-reverse-stock-split-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-announces-1-for-50-reverse-stock-split-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CNSP","CNS","BK4135"],"gpt_icon":0},{"id":"2512073101","title":"Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2512073101","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512073101?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"DALLAS, Feb.  19, 2025  (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028733/0/en/Taysha-Gene-Therapies-to-Release-Full-Year-2024-Financial-Results-and-Host-Conference-Call-and-Webcast-on-February-26.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4139","BK4218","TSHA","CNS","HST","BK4585","BK4135","BK4588"],"gpt_icon":0},{"id":"2512974441","title":"Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2512974441","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512974441?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:25","pubTimestamp":1739913900,"startTime":"0","endTime":"0","summary":"Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS total score compared to placeboSPN-820 was well-tolerated w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3028344/19871/en/Supernus-Announces-Topline-Results-from-Phase-2b-Study-in-Adults-with-Treatment-Resistant-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","PD","LU1169589451.USD","BK4135","CNS","ADHD","LU1169590202.USD"],"gpt_icon":0},{"id":"2512160948","title":"Europe Approves Merck's Cancer Drug For Two Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2512160948","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512160948?lang=en_us&edition=fundamental","pubTime":"2025-02-19 01:00","pubTimestamp":1739898040,"startTime":"0","endTime":"0","summary":"On Tuesday, the European Commission  conditionally approved Merck& Co Inc’s  Welireg, an oral hypoxia-inducible factor-2 alpha  inhibitor, as monotherapy for:. Adult patients with von Hippel-Lindau  disease who require therapy for associated, localized renal cell carcinoma , central nervous system  hemangioblastomas, or pancreatic neuroendocrine tumors , and for whom localized procedures are unsuitable;Adult patients with advanced clear cell RCC that progressed following two or more lines of therapy.The approval of these two indications is based on results from the LITESPARK-004 and LITESPARK-005 trials, respectively.Also Read: Analysts Defend Merck Amid Investor Concerns Over Weak Guidance. This marks Welireg’s first approval in the European Union . Welireg is now approved in over 30 countries for certain adult patients with previously treated advanced RCC and in more than 40 countries for adult patients with certain eligible VHL disease-associated tumors.The FDA approved Welireg in A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/europe-approves-mercks-cancer-drug-170040277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1934455863.HKD","LU0058720904.USD","RCC","LU1917777945.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU0203347892.USD","LU0320765489.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU1989772923.USD","SG9999002224.SGD","SG9999002232.USD","CNS","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU1037948541.HKD","LU0985320562.USD","IE00BFTCPJ56.SGD","MRK","LU1162221912.USD","LU2461242641.AUD","LU1116320737.USD","BK4585","LU1116320901.HKD","IE00BBT3K403.USD","LU0289739699.SGD","BK4007","IE00BN8TJ469.HKD","LU1066051225.USD","IE00BJT1NW94.SGD","LU0211331839.USD","LU1989772840.SGD","LU0106261372.USD","IE0009355771.USD","LU2361045086.USD","LU0965509101.SGD","SG9999014575.USD","LU2361044865.SGD","LU1929549753.HKD","EC","LU0070302665.USD","LU1941712348.USD","LU1291159041.SGD","LU0266013472.USD","LU0965509283.SGD","LU1934455194.USD","LU1989771016.USD","SG9999014542.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNS\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-12","defaultRemindTime":1747056600000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-12","currency":"USD","dateTimestamp":1747022400000,"payDate":"2025-05-22"},{"date":"2025-04-16","symbol":"CNS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1744833600000,"name":null,"time":"Post Market","dateTimestamp":1744776000000,"actualEps":null},{"date":"2025-03-03","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-13"},{"market":"US","date":"2025-01-22","symbol":"CNS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"post","actualEps":0.78},{"date":"2024-11-18","symbol":"CNS","amount":0.59,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-18","defaultRemindTime":1731940200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-02","payableDate":"2024-11-18","currency":"USD","dateTimestamp":1731906000000,"payDate":"2024-12-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNS\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-29","recordDate":"2015-06-02","paymentDate":"2015-06-25","value":0.25,"currency":"USD"},{"executeDate":"2015-09-01","recordDate":"2015-09-03","paymentDate":"2015-09-24","value":0.25,"currency":"USD"},{"executeDate":"2015-11-23","recordDate":"2015-11-25","paymentDate":"2015-12-16","value":0.75,"currency":"USD"},{"executeDate":"2016-03-07","recordDate":"2016-03-09","paymentDate":"2016-03-23","value":0.26,"currency":"USD"},{"executeDate":"2016-05-31","recordDate":"2016-06-02","paymentDate":"2016-06-23","value":0.26,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1729137600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNS","date":"2025-05-06","current":25.135897,"percent":0.459638,"low":12.87852,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"high":43.702499,"avg":26.236285,"sd":7.578887,"marketCap":3947316126},"quantilePoints":[{"date":"2020-05-08","current":24.886471,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":3052325677},{"date":"2020-05-15","current":23.172849,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":2842149887},{"date":"2020-05-22","current":24.878682,"twenty":17.91219,"median":21.888209,"eighty":25.763067,"marketCap":3051370333},{"date":"2020-05-29","current":24.75016,"twenty":17.91219,"median":21.888209,"eighty":25.782303,"marketCap":3035607148},{"date":"2020-06-05","current":28.695386,"twenty":17.91219,"median":21.888209,"eighty":25.792568,"marketCap":3519489138},{"date":"2020-06-12","current":26.802613,"twenty":17.91219,"median":21.888209,"eighty":25.860348,"marketCap":3287340424},{"date":"2020-06-19","current":27.643845,"twenty":17.91219,"median":21.929604,"eighty":25.901982,"marketCap":3390517630},{"date":"2020-06-26","current":25.143514,"twenty":17.91219,"median":21.929604,"eighty":25.953213,"marketCap":3083852046},{"date":"2020-07-02","current":26.319683,"twenty":17.91219,"median":21.967124,"eighty":25.986175,"marketCap":3228109065},{"date":"2020-07-10","current":26.152215,"twenty":17.91219,"median":22.016567,"eighty":25.992492,"marketCap":3207569158},{"date":"2020-07-17","current":26.362523,"twenty":17.91219,"median":22.08441,"eighty":26.071486,"marketCap":3233363460},{"date":"2020-07-24","current":25.339106,"twenty":17.91219,"median":22.145224,"eighty":26.111636,"marketCap":3036562493},{"date":"2020-07-31","current":23.987847,"twenty":17.91219,"median":22.179183,"eighty":26.111636,"marketCap":2874631600},{"date":"2020-08-07","current":24.132484,"twenty":17.91219,"median":22.253822,"eighty":26.111636,"marketCap":2891964508},{"date":"2020-08-14","current":24.666724,"twenty":17.935145,"median":22.29366,"eighty":26.111636,"marketCap":2955986191},{"date":"2020-08-21","current":24.654763,"twenty":17.935145,"median":22.345044,"eighty":26.111636,"marketCap":2954552870},{"date":"2020-08-28","current":24.499276,"twenty":17.958411,"median":22.424008,"eighty":26.111636,"marketCap":2935919693},{"date":"2020-09-04","current":23.969023,"twenty":18.000138,"median":22.496172,"eighty":26.111636,"marketCap":2872375785},{"date":"2020-09-11","current":23.263348,"twenty":18.099298,"median":22.501958,"eighty":26.111636,"marketCap":2787809831},{"date":"2020-09-18","current":22.832767,"twenty":18.192403,"median":22.546509,"eighty":26.111636,"marketCap":2736210266},{"date":"2020-09-25","current":22.155,"twenty":18.28108,"median":22.546509,"eighty":26.111636,"marketCap":2654988728},{"date":"2020-10-02","current":22.705187,"twenty":18.403976,"median":22.566583,"eighty":26.111636,"marketCap":2720921506},{"date":"2020-10-09","current":23.602231,"twenty":18.52773,"median":22.594828,"eighty":26.111636,"marketCap":2828420600},{"date":"2020-10-16","current":23.598244,"twenty":18.562573,"median":22.670837,"eighty":26.111636,"marketCap":2827942826},{"date":"2020-10-23","current":23.437391,"twenty":18.624451,"median":22.7205,"eighty":26.111636,"marketCap":2759143406},{"date":"2020-10-30","current":22.852978,"twenty":18.788661,"median":22.762059,"eighty":26.111636,"marketCap":2690343986},{"date":"2020-11-06","current":23.997588,"twenty":18.837817,"median":22.78812,"eighty":26.111636,"marketCap":2825092062},{"date":"2020-11-13","current":25.820138,"twenty":18.884452,"median":22.835905,"eighty":26.122473,"marketCap":3039649967},{"date":"2020-11-20","current":28.109489,"twenty":18.914144,"median":22.857139,"eighty":26.15386,"marketCap":3309161456},{"date":"2020-11-27","current":29.432766,"twenty":18.924936,"median":22.889551,"eighty":26.180357,"marketCap":3464942919},{"date":"2020-12-04","current":30.557145,"twenty":18.972497,"median":22.931471,"eighty":26.234833,"marketCap":3597309378},{"date":"2020-12-11","current":30.5815,"twenty":19.026142,"median":22.993772,"eighty":26.256821,"marketCap":3600176521},{"date":"2020-12-18","current":30.191823,"twenty":19.058337,"median":23.028301,"eighty":26.31233,"marketCap":3554302225},{"date":"2020-12-24","current":29.794029,"twenty":19.093721,"median":23.060018,"eighty":26.337042,"marketCap":3507472215},{"date":"2020-12-31","current":30.15935,"twenty":19.103205,"median":23.125625,"eighty":26.362312,"marketCap":3550479367},{"date":"2021-01-08","current":29.091799,"twenty":19.162181,"median":23.160033,"eighty":26.401457,"marketCap":3424802910},{"date":"2021-01-15","current":29.887389,"twenty":19.202231,"median":23.200606,"eighty":26.441488,"marketCap":3518462931},{"date":"2021-01-22","current":29.74126,"twenty":19.221971,"median":23.235659,"eighty":26.487931,"marketCap":3501260070},{"date":"2021-01-29","current":40.869698,"twenty":19.278958,"median":23.263348,"eighty":26.526288,"marketCap":3129964987},{"date":"2021-02-05","current":42.298578,"twenty":19.312251,"median":23.304616,"eighty":26.539566,"marketCap":3239394297},{"date":"2021-02-12","current":43.072294,"twenty":19.369502,"median":23.346381,"eighty":26.568376,"marketCap":3298648596},{"date":"2021-02-19","current":41.312714,"twenty":19.404944,"median":23.412011,"eighty":26.604536,"marketCap":3163892852},{"date":"2021-02-26","current":40.543706,"twenty":19.462875,"median":23.44404,"eighty":26.627953,"marketCap":3104999179},{"date":"2021-03-05","current":41.494638,"twenty":19.519205,"median":23.521823,"eighty":26.663067,"marketCap":3177825348},{"date":"2021-03-12","current":42.773043,"twenty":19.606366,"median":23.562376,"eighty":26.674223,"marketCap":3275730727},{"date":"2021-03-19","current":41.356092,"twenty":19.606366,"median":23.598948,"eighty":26.704024,"marketCap":3167214913},{"date":"2021-03-26","current":40.990833,"twenty":19.607142,"median":23.626615,"eighty":26.73796,"marketCap":3139241947},{"date":"2021-04-01","current":42.307023,"twenty":19.607142,"median":23.674531,"eighty":26.795994,"marketCap":3240041082},{"date":"2021-04-09","current":41.878789,"twenty":19.606366,"median":23.704202,"eighty":26.872012,"marketCap":3207245191},{"date":"2021-04-16","current":42.502248,"twenty":19.606366,"median":23.710206,"eighty":26.913332,"marketCap":3254992149},{"date":"2021-04-23","current":31.693219,"twenty":19.606366,"median":23.710206,"eighty":27.029751,"marketCap":3323477686},{"date":"2021-04-30","current":31.283888,"twenty":19.606366,"median":23.755094,"eighty":27.056161,"marketCap":3280553653},{"date":"2021-05-07","current":32.560979,"twenty":19.606366,"median":23.782134,"eighty":27.213028,"marketCap":3414474551},{"date":"2021-05-14","current":33.61905,"twenty":19.606366,"median":23.8007,"eighty":27.25402,"marketCap":3525428090},{"date":"2021-05-21","current":33.200422,"twenty":19.606366,"median":23.839623,"eighty":27.262589,"marketCap":3481529081},{"date":"2021-05-28","current":33.642052,"twenty":19.606366,"median":23.883463,"eighty":27.340067,"marketCap":3527840123},{"date":"2021-06-04","current":34.226291,"twenty":19.606366,"median":23.921975,"eighty":27.431277,"marketCap":3589105773},{"date":"2021-06-11","current":34.424104,"twenty":19.606366,"median":23.95944,"eighty":27.60508,"marketCap":3609849261},{"date":"2021-06-18","current":35.633985,"twenty":19.606366,"median":23.983072,"eighty":27.65774,"marketCap":3736722220},{"date":"2021-06-25","current":37.754727,"twenty":19.606366,"median":24.001439,"eighty":27.731371,"marketCap":3959111704},{"date":"2021-07-02","current":37.317698,"twenty":19.606366,"median":24.019996,"eighty":27.803594,"marketCap":3913283069},{"date":"2021-07-09","current":36.871468,"twenty":19.606366,"median":24.065621,"eighty":27.878924,"marketCap":3866489620},{"date":"2021-07-16","current":36.443639,"twenty":19.606366,"median":24.065621,"eighty":27.954254,"marketCap":3821625798},{"date":"2021-07-23","current":32.23161,"twenty":19.606366,"median":24.065621,"eighty":28.3446,"marketCap":3962006144},{"date":"2021-07-30","current":32.655452,"twenty":19.606366,"median":24.065621,"eighty":28.597983,"marketCap":4014106067},{"date":"2021-08-06","current":34.262979,"twenty":19.606366,"median":24.065621,"eighty":28.779046,"marketCap":4211708107},{"date":"2021-08-13","current":34.608395,"twenty":19.606366,"median":24.065621,"eighty":28.919847,"marketCap":4254167761},{"date":"2021-08-20","current":34.376809,"twenty":19.606366,"median":24.065621,"eighty":29.018684,"marketCap":4225700493},{"date":"2021-08-27","current":34.690824,"twenty":19.606366,"median":24.065621,"eighty":29.125292,"marketCap":4264300178},{"date":"2021-09-03","current":34.518116,"twenty":19.606366,"median":24.065621,"eighty":29.237927,"marketCap":4243070351},{"date":"2021-09-10","current":34.015692,"twenty":19.606366,"median":24.065621,"eighty":29.325721,"marketCap":4181310855},{"date":"2021-09-17","current":34.235502,"twenty":19.606366,"median":24.065621,"eighty":29.428707,"marketCap":4208330635},{"date":"2021-09-24","current":33.650649,"twenty":19.606366,"median":24.065621,"eighty":29.513948,"marketCap":4136438722},{"date":"2021-10-01","current":33.485791,"twenty":19.606366,"median":24.065621,"eighty":29.715133,"marketCap":4116173887},{"date":"2021-10-08","current":33.897936,"twenty":19.607142,"median":24.072911,"eighty":29.833679,"marketCap":4166835974},{"date":"2021-10-15","current":34.282604,"twenty":19.607142,"median":24.072911,"eighty":29.886999,"marketCap":4214120588},{"date":"2021-10-22","current":31.39397,"twenty":19.607142,"median":24.120524,"eighty":29.97263,"marketCap":4473703468},{"date":"2021-10-29","current":32.128708,"twenty":19.607919,"median":24.159112,"eighty":30.0979,"marketCap":4578405113},{"date":"2021-11-05","current":34.01649,"twenty":19.607919,"median":24.231662,"eighty":30.206436,"marketCap":4847417859},{"date":"2021-11-12","current":33.779441,"twenty":19.607919,"median":24.272267,"eighty":30.2663,"marketCap":4813637944},{"date":"2021-11-19","current":33.335822,"twenty":19.607919,"median":24.34227,"eighty":30.314228,"marketCap":4750421245},{"date":"2021-11-26","current":31.585048,"twenty":19.607919,"median":24.388858,"eighty":30.347179,"marketCap":4500932441},{"date":"2021-12-03","current":30.152596,"twenty":19.607919,"median":24.435486,"eighty":30.418709,"marketCap":4296805238},{"date":"2021-12-10","current":30.687649,"twenty":19.607919,"median":24.495428,"eighty":30.555834,"marketCap":4373051333},{"date":"2021-12-17","current":30.917925,"twenty":19.607919,"median":24.535811,"eighty":30.628753,"marketCap":4405866108},{"date":"2021-12-23","current":30.464146,"twenty":19.607919,"median":24.549254,"eighty":30.66128,"marketCap":4341201699},{"date":"2021-12-31","current":31.32768,"twenty":19.607919,"median":24.669496,"eighty":30.712708,"marketCap":4464257105},{"date":"2022-01-07","current":30.782468,"twenty":19.609472,"median":24.728839,"eighty":30.771039,"marketCap":4386563299},{"date":"2022-01-14","current":29.597225,"twenty":19.609472,"median":24.776362,"eighty":30.771039,"marketCap":4217663722},{"date":"2022-01-21","current":28.411981,"twenty":19.609472,"median":24.864401,"eighty":30.771039,"marketCap":4048764145},{"date":"2022-01-28","current":18.641168,"twenty":19.590769,"median":24.917596,"eighty":30.771039,"marketCap":3940668416},{"date":"2022-02-04","current":18.285055,"twenty":19.499836,"median":24.917596,"eighty":30.771039,"marketCap":3865387462},{"date":"2022-02-11","current":18.433435,"twenty":19.415099,"median":24.917596,"eighty":30.771039,"marketCap":3896754526},{"date":"2022-02-18","current":18.221137,"twenty":19.383827,"median":24.917596,"eighty":30.771039,"marketCap":3851875496},{"date":"2022-02-25","current":18.59767,"twenty":19.32955,"median":24.882576,"eighty":30.771039,"marketCap":3931473126},{"date":"2022-03-04","current":17.962167,"twenty":19.282693,"median":24.776362,"eighty":30.771039,"marketCap":3797130353},{"date":"2022-03-11","current":17.870066,"twenty":19.226995,"median":24.690202,"eighty":30.771039,"marketCap":3777660385},{"date":"2022-03-18","current":19.069692,"twenty":19.199701,"median":24.590174,"eighty":30.771039,"marketCap":4031256708},{"date":"2022-03-25","current":19.266364,"twenty":19.165812,"median":24.531824,"eighty":30.771039,"marketCap":4072832201},{"date":"2022-04-01","current":20.194336,"twenty":19.165812,"median":24.414953,"eighty":30.771039,"marketCap":4269001841},{"date":"2022-04-08","current":19.798278,"twenty":19.165812,"median":24.34446,"eighty":30.771039,"marketCap":4185276833},{"date":"2022-04-14","current":19.006163,"twenty":19.164835,"median":24.272267,"eighty":30.771039,"marketCap":4017826818},{"date":"2022-04-22","current":19.515002,"twenty":19.160428,"median":24.159112,"eighty":30.771039,"marketCap":3992027833},{"date":"2022-04-29","current":18.48702,"twenty":19.120759,"median":24.109263,"eighty":30.771039,"marketCap":3781741767},{"date":"2022-05-06","current":18.140576,"twenty":19.097352,"median":24.008501,"eighty":30.771039,"marketCap":3710872529},{"date":"2022-05-13","current":17.343267,"twenty":19.068709,"median":23.966477,"eighty":30.771039,"marketCap":3547773304},{"date":"2022-05-20","current":17.248065,"twenty":19.045263,"median":23.843035,"eighty":30.771039,"marketCap":3528298769},{"date":"2022-05-27","current":18.354779,"twenty":19.014348,"median":23.76195,"eighty":30.771039,"marketCap":3754690232},{"date":"2022-06-03","current":17.897813,"twenty":18.977944,"median":23.679147,"eighty":30.771039,"marketCap":3661212467},{"date":"2022-06-10","current":16.634018,"twenty":18.947577,"median":23.585518,"eighty":30.771039,"marketCap":3402688023},{"date":"2022-06-17","current":15.608226,"twenty":18.914815,"median":23.455654,"eighty":30.689004,"marketCap":3192849914},{"date":"2022-06-24","current":16.260354,"twenty":18.900025,"median":23.315177,"eighty":30.690358,"marketCap":3326250475},{"date":"2022-07-01","current":15.477324,"twenty":18.870215,"median":23.246645,"eighty":30.690358,"marketCap":3166072430},{"date":"2022-07-08","current":15.736747,"twenty":18.832714,"median":23.109571,"eighty":30.614098,"marketCap":3219140536},{"date":"2022-07-15","current":16.162773,"twenty":18.79571,"median":22.956359,"eighty":30.520819,"marketCap":3306289077},{"date":"2022-07-22","current":16.110583,"twenty":18.706811,"median":22.835905,"eighty":30.406577,"marketCap":3382239761},{"date":"2022-07-29","current":17.089231,"twenty":18.655675,"median":22.723109,"eighty":30.285785,"marketCap":3587696099},{"date":"2022-08-05","current":17.336827,"twenty":18.60341,"median":22.666493,"eighty":30.247635,"marketCap":3639676038},{"date":"2022-08-12","current":18.014155,"twenty":18.576102,"median":22.585581,"eighty":30.247635,"marketCap":3781873710},{"date":"2022-08-19","current":17.726522,"twenty":18.553033,"median":22.523144,"eighty":30.247635,"marketCap":3721488397},{"date":"2022-08-26","current":17.097906,"twenty":18.483674,"median":22.467927,"eighty":30.247635,"marketCap":3589517270},{"date":"2022-09-02","current":16.432175,"twenty":18.396609,"median":22.353732,"eighty":30.247635,"marketCap":3449754489},{"date":"2022-09-09","current":17.31595,"twenty":18.356371,"median":22.298527,"eighty":30.247635,"marketCap":3635293233},{"date":"2022-09-16","current":16.842748,"twenty":18.283229,"median":22.249478,"eighty":30.247635,"marketCap":3535949654},{"date":"2022-09-23","current":15.91722,"twenty":18.21193,"median":22.179183,"eighty":30.247635,"marketCap":3341645300},{"date":"2022-09-30","current":14.527769,"twenty":18.176655,"median":22.123505,"eighty":30.247635,"marketCap":3049945280},{"date":"2022-10-07","current":14.019773,"twenty":18.104175,"median":22.045314,"eighty":30.247635,"marketCap":2943297026},{"date":"2022-10-14","current":12.87852,"twenty":18.032153,"median":21.992474,"eighty":30.247635,"marketCap":2703703688},{"date":"2022-10-21","current":13.875906,"twenty":17.988291,"median":21.929604,"eighty":30.247635,"marketCap":2817169639},{"date":"2022-10-28","current":14.518731,"twenty":17.957216,"median":21.836807,"eighty":30.247635,"marketCap":2947679831},{"date":"2022-11-04","current":14.228587,"twenty":17.927938,"median":21.723866,"eighty":30.232415,"marketCap":2888773025},{"date":"2022-11-11","current":16.001462,"twenty":17.901888,"median":21.670268,"eighty":30.232415,"marketCap":3248712878},{"date":"2022-11-18","current":15.814339,"twenty":17.857353,"median":21.62555,"eighty":30.232415,"marketCap":3210721932},{"date":"2022-11-25","current":15.672797,"twenty":17.824307,"median":21.559545,"eighty":30.232415,"marketCap":3181985192},{"date":"2022-12-02","current":16.212576,"twenty":17.737907,"median":21.517024,"eighty":30.232415,"marketCap":3291574457},{"date":"2022-12-09","current":16.03025,"twenty":17.634502,"median":21.398073,"eighty":30.232415,"marketCap":3254557638},{"date":"2022-12-16","current":15.432895,"twenty":17.536399,"median":21.363322,"eighty":30.232415,"marketCap":3133278852},{"date":"2022-12-23","current":15.157007,"twenty":17.453772,"median":21.291372,"eighty":30.232415,"marketCap":3077266561},{"date":"2022-12-30","current":15.488072,"twenty":17.435795,"median":21.271518,"eighty":30.232415,"marketCap":3144481310},{"date":"2023-01-06","current":16.500458,"twenty":17.354712,"median":21.218395,"eighty":30.232415,"marketCap":3350022065},{"date":"2023-01-13","current":17.735954,"twenty":17.299707,"median":21.152857,"eighty":30.232415,"marketCap":3600859716},{"date":"2023-01-20","current":17.532037,"twenty":17.272433,"median":21.104444,"eighty":30.232415,"marketCap":3559459327},{"date":"2023-01-27","current":20.240915,"twenty":17.272433,"median":21.102629,"eighty":30.232415,"marketCap":3462046647},{"date":"2023-02-03","current":21.659032,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3704604220},{"date":"2023-02-10","current":21.055336,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3601346779},{"date":"2023-02-17","current":21.129374,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3614010428},{"date":"2023-02-24","current":20.698656,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3540339494},{"date":"2023-03-03","current":20.580952,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3520207189},{"date":"2023-03-10","current":18.634532,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3187287608},{"date":"2023-03-17","current":18.169458,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3107740452},{"date":"2023-03-24","current":17.469835,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":2988075455},{"date":"2023-03-31","current":18.362705,"twenty":17.273887,"median":21.10979,"eighty":30.224296,"marketCap":3140793856},{"date":"2023-04-06","current":17.72248,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":3031288379},{"date":"2023-04-14","current":17.659318,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3020485148},{"date":"2023-04-20","current":18.415569,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3026377819},{"date":"2023-04-28","current":17.701417,"twenty":17.269524,"median":21.116232,"eighty":30.248652,"marketCap":2909015447},{"date":"2023-05-05","current":16.207374,"twenty":17.258712,"median":21.116232,"eighty":30.248652,"marketCap":2663487472},{"date":"2023-05-12","current":16.342745,"twenty":17.216458,"median":21.122803,"eighty":30.25677,"marketCap":2685734018},{"date":"2023-05-19","current":16.937516,"twenty":17.1325,"median":21.129374,"eighty":30.263026,"marketCap":2783477447},{"date":"2023-05-26","current":16.037888,"twenty":17.093405,"median":21.143612,"eighty":30.269283,"marketCap":2635634371},{"date":"2023-06-01","current":16.262047,"twenty":17.038241,"median":21.15785,"eighty":30.275539,"marketCap":2672472347},{"date":"2023-06-09","current":18.405015,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3024643395},{"date":"2023-06-16","current":18.36915,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3018749319},{"date":"2023-06-23","current":17.173631,"twenty":16.999409,"median":21.167314,"eighty":30.322625,"marketCap":2822280115},{"date":"2023-06-30","current":17.421701,"twenty":16.956799,"median":21.19089,"eighty":30.357198,"marketCap":2863047475},{"date":"2023-07-07","current":17.176619,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":2822771288},{"date":"2023-07-14","current":19.140259,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":3145471956},{"date":"2023-07-21","current":22.272461,"twenty":16.9482,"median":21.240006,"eighty":30.381903,"marketCap":3210797966},{"date":"2023-07-28","current":22.401932,"twenty":16.944638,"median":21.281264,"eighty":30.385612,"marketCap":3229462540},{"date":"2023-08-04","current":21.798869,"twenty":16.944638,"median":21.362879,"eighty":30.385612,"marketCap":3142524917},{"date":"2023-08-11","current":22.605317,"twenty":16.944638,"median":21.393729,"eighty":30.385612,"marketCap":3258782486},{"date":"2023-08-18","current":21.616995,"twenty":16.944638,"median":21.462546,"eighty":30.385612,"marketCap":3116305941},{"date":"2023-08-25","current":21.323906,"twenty":16.944638,"median":21.480607,"eighty":30.385612,"marketCap":3074054276},{"date":"2023-09-01","current":22.213396,"twenty":16.941077,"median":21.556303,"eighty":30.389322,"marketCap":3202283166},{"date":"2023-09-08","current":21.569282,"twenty":16.941077,"median":21.60996,"eighty":30.389322,"marketCap":3109427763},{"date":"2023-09-15","current":21.882819,"twenty":16.941077,"median":21.616127,"eighty":30.389322,"marketCap":3154627219},{"date":"2023-09-22","current":21.061489,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3036224297},{"date":"2023-09-29","current":21.156914,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3049980653},{"date":"2023-10-05","current":20.373072,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":2936982014},{"date":"2023-10-13","current":19.302957,"twenty":16.962706,"median":21.62555,"eighty":30.393031,"marketCap":2782714307},{"date":"2023-10-20","current":19.766808,"twenty":17.094797,"median":21.635278,"eighty":30.394386,"marketCap":2603881679},{"date":"2023-10-27","current":19.173804,"twenty":17.14802,"median":21.654483,"eighty":30.398449,"marketCap":2525765228},{"date":"2023-11-03","current":20.624613,"twenty":17.21745,"median":21.654483,"eighty":30.398449,"marketCap":2716880317},{"date":"2023-11-10","current":19.788994,"twenty":17.261187,"median":21.654483,"eighty":30.398449,"marketCap":2606804215},{"date":"2023-11-17","current":21.859285,"twenty":17.306392,"median":21.660629,"eighty":30.398449,"marketCap":2879523600},{"date":"2023-11-24","current":21.113234,"twenty":17.347082,"median":21.667395,"eighty":30.398449,"marketCap":2781246344},{"date":"2023-12-01","current":21.818252,"twenty":17.382449,"median":21.672805,"eighty":30.398449,"marketCap":2874118351},{"date":"2023-12-08","current":23.530438,"twenty":17.431804,"median":21.701465,"eighty":30.398449,"marketCap":3099664654},{"date":"2023-12-15","current":27.555382,"twenty":17.450036,"median":21.745585,"eighty":30.398449,"marketCap":3629870450},{"date":"2023-12-22","current":27.365139,"twenty":17.496342,"median":21.810744,"eighty":30.398449,"marketCap":3604809750},{"date":"2023-12-29","current":28.827398,"twenty":17.527254,"median":21.852697,"eighty":30.399804,"marketCap":3797433171},{"date":"2024-01-05","current":26.820522,"twenty":17.571979,"median":21.883893,"eighty":30.40319,"marketCap":3533067353},{"date":"2024-01-12","current":25.46644,"twenty":17.607846,"median":21.929604,"eighty":30.40319,"marketCap":3354694133},{"date":"2024-01-19","current":24.690547,"twenty":17.644846,"median":21.986315,"eighty":30.406577,"marketCap":3252485787},{"date":"2024-01-26","current":26.760864,"twenty":17.711966,"median":22.045314,"eighty":30.40319,"marketCap":3453462775},{"date":"2024-02-02","current":27.042638,"twenty":17.738956,"median":22.116155,"eighty":30.40319,"marketCap":3489825360},{"date":"2024-02-09","current":26.34582,"twenty":17.7688,"median":22.15546,"eighty":30.40319,"marketCap":3399901671},{"date":"2024-02-16","current":27.141639,"twenty":17.80097,"median":22.213396,"eighty":30.40319,"marketCap":3502601403},{"date":"2024-02-23","current":27.30918,"twenty":17.835673,"median":22.249478,"eighty":30.40319,"marketCap":3524222400},{"date":"2024-03-01","current":28.224884,"twenty":17.840133,"median":22.284274,"eighty":30.399804,"marketCap":3642393114},{"date":"2024-03-08","current":29.072974,"twenty":17.854544,"median":22.345044,"eighty":30.399804,"marketCap":3751838236},{"date":"2024-03-15","current":26.943156,"twenty":17.854544,"median":22.410631,"eighty":30.399804,"marketCap":3476987362},{"date":"2024-03-22","current":29.203449,"twenty":17.862113,"median":22.484099,"eighty":30.399804,"marketCap":3768675948},{"date":"2024-03-28","current":29.116605,"twenty":17.870066,"median":22.523144,"eighty":30.399804,"marketCap":3757468730},{"date":"2024-04-05","current":28.065076,"twenty":17.868475,"median":22.583959,"eighty":30.40319,"marketCap":3621769977},{"date":"2024-04-12","current":27.869353,"twenty":17.868475,"median":22.609066,"eighty":30.40319,"marketCap":3596512181},{"date":"2024-04-19","current":25.6312,"twenty":17.868475,"median":22.695824,"eighty":30.40319,"marketCap":3274103832},{"date":"2024-04-26","current":27.635851,"twenty":17.870066,"median":22.753371,"eighty":30.399804,"marketCap":3530175929},{"date":"2024-05-03","current":27.556733,"twenty":17.870066,"median":22.836196,"eighty":30.399804,"marketCap":3520069499},{"date":"2024-05-10","current":29.163628,"twenty":17.870066,"median":22.943915,"eighty":30.399804,"marketCap":3725332736},{"date":"2024-05-17","current":29.183411,"twenty":17.870066,"median":23.090775,"eighty":30.399804,"marketCap":3727859756},{"date":"2024-05-24","current":28.221973,"twenty":17.870066,"median":23.209747,"eighty":30.399804,"marketCap":3605046589},{"date":"2024-05-31","current":27.054795,"twenty":17.870066,"median":23.285328,"eighty":30.399804,"marketCap":3455952415},{"date":"2024-06-07","current":27.822363,"twenty":17.870066,"median":23.445508,"eighty":30.399804,"marketCap":3554000787},{"date":"2024-06-14","current":28.154712,"twenty":17.868475,"median":23.529127,"eighty":30.40319,"marketCap":3596454721},{"date":"2024-06-21","current":28.269451,"twenty":17.866885,"median":23.600941,"eighty":30.406577,"marketCap":3611111437},{"date":"2024-06-28","current":28.00832,"twenty":17.862113,"median":23.655779,"eighty":30.416736,"marketCap":3577754774},{"date":"2024-07-05","current":28.550365,"twenty":17.862113,"median":23.741772,"eighty":30.416736,"marketCap":3646995119},{"date":"2024-07-12","current":29.808544,"twenty":17.862113,"median":23.829483,"eighty":30.416736,"marketCap":3807713585},{"date":"2024-07-15","current":30.034066,"twenty":17.862113,"median":23.84751,"eighty":30.416736,"marketCap":3836521612},{"date":"2024-08-02","current":33.347515,"twenty":17.848785,"median":23.979228,"eighty":30.525101,"marketCap":4259544743},{"date":"2024-08-09","current":32.935122,"twenty":17.848785,"median":24.052267,"eighty":30.630396,"marketCap":4206869033},{"date":"2024-08-16","current":33.287348,"twenty":17.848785,"median":24.123689,"eighty":30.714063,"marketCap":4251859581},{"date":"2024-08-23","current":33.750387,"twenty":17.848785,"median":24.183737,"eighty":30.826419,"marketCap":4311004459},{"date":"2024-08-30","current":34.755617,"twenty":17.848785,"median":24.299974,"eighty":30.970882,"marketCap":4439404451},{"date":"2024-09-06","current":34.79915,"twenty":17.848785,"median":24.36742,"eighty":31.120432,"marketCap":4444965081},{"date":"2024-09-13","current":35.404663,"twenty":17.848785,"median":24.435486,"eighty":31.286647,"marketCap":4522308383},{"date":"2024-09-20","current":37.834627,"twenty":17.848785,"median":24.535811,"eighty":31.405188,"marketCap":4832692616},{"date":"2024-09-27","current":37.620917,"twenty":17.848785,"median":24.628464,"eighty":31.548301,"marketCap":4805394980},{"date":"2024-10-04","current":36.576111,"twenty":17.848785,"median":24.693686,"eighty":31.671335,"marketCap":4671939870},{"date":"2024-10-11","current":36.342613,"twenty":17.848785,"median":24.776362,"eighty":31.921404,"marketCap":4642114675},{"date":"2024-10-18","current":39.372812,"twenty":17.848785,"median":24.882576,"eighty":32.212468,"marketCap":5325566602},{"date":"2024-10-25","current":37.545256,"twenty":17.848785,"median":25.007411,"eighty":32.383174,"marketCap":5078371341},{"date":"2024-10-31","current":37.732123,"twenty":17.848785,"median":25.038793,"eighty":32.531573,"marketCap":5103646930},{"date":"2024-11-08","current":38.195552,"twenty":17.848309,"median":25.036169,"eighty":32.647241,"marketCap":5166330391},{"date":"2024-11-15","current":37.647327,"twenty":17.848309,"median":25.05345,"eighty":32.844946,"marketCap":5092177385},{"date":"2024-11-22","current":38.12203,"twenty":17.848309,"median":25.05345,"eighty":32.996976,"marketCap":5156385738},{"date":"2024-11-29","current":39.120028,"twenty":17.848309,"median":25.05345,"eighty":33.070314,"marketCap":5291374952},{"date":"2024-12-06","current":37.834218,"twenty":17.848309,"median":25.05345,"eighty":33.177608,"marketCap":5117456264},{"date":"2024-12-13","current":37.6249,"twenty":17.848309,"median":25.05345,"eighty":33.254869,"marketCap":5089143920},{"date":"2024-12-20","current":33.890817,"twenty":17.848309,"median":25.143514,"eighty":33.332395,"marketCap":4584071917},{"date":"2024-12-27","current":35.344829,"twenty":17.848309,"median":25.20584,"eighty":33.433016,"marketCap":4780741596},{"date":"2025-01-03","current":34.152464,"twenty":17.848309,"median":25.316828,"eighty":33.484887,"marketCap":4619462348},{"date":"2025-01-10","current":33.449754,"twenty":17.847833,"median":25.412351,"eighty":33.512931,"marketCap":4524413763},{"date":"2025-01-17","current":32.918984,"twenty":17.847833,"median":25.627156,"eighty":33.512931,"marketCap":4452621747},{"date":"2025-01-24","current":29.843666,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4514302211},{"date":"2025-01-31","current":29.689919,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4491045643},{"date":"2025-02-07","current":29.850351,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4515313366},{"date":"2025-02-14","current":28.209267,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4267074775},{"date":"2025-02-21","current":28.924526,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4375268377},{"date":"2025-02-28","current":29.116429,"twenty":17.847833,"median":25.724336,"eighty":33.512931,"marketCap":4404296702},{"date":"2025-03-07","current":28.988386,"twenty":17.846293,"median":25.852331,"eighty":33.522419,"marketCap":4384928194},{"date":"2025-03-14","current":25.446971,"twenty":17.849737,"median":25.966294,"eighty":33.522419,"marketCap":3849236048},{"date":"2025-03-21","current":26.589254,"twenty":17.892782,"median":26.105931,"eighty":33.522419,"marketCap":4022023524},{"date":"2025-03-28","current":26.946428,"twenty":17.939383,"median":26.181536,"eighty":33.522419,"marketCap":4076051467},{"date":"2025-04-04","current":25.986102,"twenty":17.978554,"median":26.303934,"eighty":33.522419,"marketCap":3930787659},{"date":"2025-04-11","current":24.851655,"twenty":18.014155,"median":26.294159,"eighty":33.512931,"marketCap":3759185663},{"date":"2025-04-17","current":23.983353,"twenty":18.072738,"median":26.294159,"eighty":33.512931,"marketCap":3766321745},{"date":"2025-04-25","current":24.944115,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3917198891},{"date":"2025-05-02","current":24.905165,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3911082250},{"date":"2025-05-06","current":25.135897,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3947316126}],"updateTime":1746659702625}}}